Antonino Musolino

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 955 citations · Full text

Medicine, Immunology, Oncology +17

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Valentina Guarneri, Antonio Frassoldati, Alberto Bottini et al. · Journal of Clinical Oncology · 2012 · 368 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · JAMA Oncology · 2021 · 349 citations · Full text

Medicine, Oncology, Pharmacology +17

Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer

Nicholas C. Turner, Seock‐Ah Im, Cristina Saura et al. · New England Journal of Medicine · 2024 · 237 citations

Medicine, Oncology, Pharmacology +16

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

PierFranco Conte, Antonio Frassoldati, Giancarlo Bisagni et al. · Annals of Oncology · 2018 · 155 citations · Full text

Medicine, Oncology, Pharmacotherapy +17